亚宝药业集团股份有限公司2025年半年度报告摘要

Core Viewpoint - The company, Yabao Pharmaceutical Group Co., Ltd., is set to hold a half-year performance briefing on August 25, 2025, to discuss its operational results and financial status for the first half of 2025, allowing investors to engage in Q&A sessions [5][6][7]. Group 1: Company Overview - The company has confirmed that all board members attended the board meeting [2]. - The half-year report has not been audited [2]. - There are no proposed profit distribution plans or capital reserve transfers for the reporting period [3]. Group 2: Financial Data - The company has not disclosed specific financial data in the provided documents, indicating that detailed financial results will be discussed during the upcoming performance briefing [3]. Group 3: Important Events - The performance briefing will take place on August 25, 2025, from 15:00 to 16:00 at the Shanghai Stock Exchange Roadshow Center, and will be conducted in an interactive online format [5][8]. - Investors can submit questions for the briefing from August 18 to August 22, 2025, through the designated website or via email [9]. - Key personnel attending the briefing include the Vice Chairman and General Manager, the Board Secretary, and the Chief Financial Officer [7].